Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia

Clinical trial NCT04562792 · COMPLETED

Trial details

NCT number: NCT04562792
Sponsor: Children's Mercy Hospital Kansas City
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Pediatric ALL Relapsed Pediatric AML Refractory Acute Myeloid Leukemia Refractory Acute Lymphoblastic Leukemia

Start date: 2020-05-08
Primary completion: 2022-06-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.